Your browser doesn't support javascript.
loading
Effectiveness and Safety of Reference Infliximab and Biosimilar in Crohn Disease: A French Equivalence Study.
Meyer, Antoine; Rudant, Jérémie; Drouin, Jérôme; Weill, Alain; Carbonnel, Franck; Coste, Joël.
Affiliation
  • Meyer A; Caisse Nationale de l'Assurance Maladie, Paris, and Hôpital Bicêtre, Le Kremlin-Bicêtre, France. (A.M.).
  • Rudant J; Caisse Nationale de l'Assurance Maladie, Paris, France (J.R., J.D., A.W.).
  • Drouin J; Caisse Nationale de l'Assurance Maladie, Paris, France (J.R., J.D., A.W.).
  • Weill A; Caisse Nationale de l'Assurance Maladie, Paris, France (J.R., J.D., A.W.).
  • Carbonnel F; Hôpital Bicêtre, Le Kremlin-Bicêtre, France (F.C.).
  • Coste J; Caisse Nationale de l'Assurance Maladie, Paris, and Hôpital Bicêtre, Le Kremlin-Bicêtre, France (J.C.).
Ann Intern Med ; 170(2): 99-107, 2019 01 15.
Article in En | MEDLINE | ID: mdl-30534946
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Agents / Crohn Disease / Biosimilar Pharmaceuticals / Infliximab / Antibodies, Monoclonal Type of study: Observational_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Ann Intern Med Year: 2019 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Agents / Crohn Disease / Biosimilar Pharmaceuticals / Infliximab / Antibodies, Monoclonal Type of study: Observational_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Ann Intern Med Year: 2019 Document type: Article Country of publication: